Technetium-99m sestamibi single photon emission computed tomography findings correlated with P-glycoprotein expression in pituitary adenoma

Journal of Medical Investigation

Volumn 53, Issue 3-4, 2006, Pages 285-291

  Kunishio, Katsuzo ^a,b   Okada, Maski ^a   Matsumoto, Yoshihito ^a   Nagao, Seigo ^a   Nishiyama, Yoshihiro ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

MIBI SPECT; P glycoprotein; Pituitary adenoma; Proliferative potential

Indexed keywords

CORTICOTROPIN; GLYCOPROTEIN P; GLYCOPROTEIN P INHIBITOR; MESSENGER RNA; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MONOCLONAL ANTIBODY; MULTIDRUG RESISTANCE PROTEIN 1;

ADULT; AGED; ARTICLE; CANCER INVASION; CAVERNOUS SINUS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN CELL; HYPOPHYSIS ADENOMA; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; NEUROIMAGING; PROLACTINOMA; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR CELL;

ADULT; AGED; CAVERNOUS SINUS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MDR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; P-GLYCOPROTEIN; PITUITARY NEOPLASMS; RNA, MESSENGER; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33750350909     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: 10.2152/jmi.53.285     Document Type: Article

References (34)

1. Acquati S, Pizzocaro A, Tomei G, Giovanelli M, Libe R, Faglia G, Ambrosi B: A comparative evaluation of effectiveness of medical and surgical therapy in patients with macroprolactinoma. J Neurosurg Sci Jun 45: 65-69, 2001
2. Meij BP, Lopes MB, Ellegala DB, Alden TD, Laws ER Jr: The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. J Neurosurg 96: 195-208, 2002
3. Nakase H, Ohnishi H, Matsuyama T, Morimoto T, Sakaki T: Two-stage skull base surgery for tumours extending to the sub- and epidural spaces. Acta Neurochir (Wien) 140: 891-898, 1998
4. Black KL, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D: Use of thalium-201 SPECT to quantative malignancy grade of gliomas. J Neurosurg 71: 342-6, 1989
5. Oriuchi N, Tamura M, Shibazaki T, Ohye C, Watanabe N, Tateno M, Tomiyoshi K, Hirano T, Inoue T, Endo K: Clinical evaluation of thalium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities. J Nucl Med 34: 2085-9, 1993
6. 201Tl SPECT for evaluation of biologic behavior in pituitary adenomas. J Nucl Med 42: 575-8, 2001
7. Baillet G, Albuquerque L, Chen Q, Poisson M, Delattre JY: Evaluation of single-photon emission tomography imaging of supratentorial brain gliomas with technetium-99 m sestamibi. Eur J Nucl Med 21: 1061-1066, 1994
8. 201Tl. Neuroradiology 43: 1023-1030, 2001
9. 99mTc-sestamibi SPECT? Eur J Nucl Med 25: 401-409, 1998
10. Ballinger JR, Hua HA, Berry BW, Firby P, Boxen I: Technetium-99m- sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistance variant. Nucl Med Commun 16: 253-257, 1995
11. Hendrikse NH, Franssen EJF, van der Graaf WTA, Vaalburg W, de Vries EGE: Visualization of multidrug resistance in vivo. Eur J Nucl Med 26: 283-293, 1999
12. Kostakoglu L, Ruacan S, Ergun EL, Sayek I, Elahi N, Bekdik CF: Influence of the heterogeneity of P-glycoprotein expression on technetium-99m-MIBI uptake in breast cancer. J Nucl Med 39: 1021-1026, 1998
13. Piwinca-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM: Functional imaging of mutidrug-resistance P glycoprotein with an organotechnetium complex. Cancer Res 53: 977-984, 1993
14. 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes. Eur J Biochem 252: 140-146, 1998
15. Knosp E, Steiner E, Kitz K, Matula C: Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 3: 610-618, 1993
16. Lee JS, Scala S, Matsumoto Y, Dickstein B, Robey R, Zhan Z, Altenberg G, Bates SE: Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression. J Cell Biochem 65: 513-526, 1997
17. Dierckx RA, Martin JJ, Dobbleleir A Crols R, Neetens I, De Deyn PP: Sensitivity and specificity of thalium-201 single-photon emission tomography in the functional detection and differential diagnosis of tumours. Eur J Nucl Med 21: 621-633, 1994
18. Ishibashi M, Taguchi A, Sugita Y, Morita S, Kawamura S, Umezaki N, Shigemori M, Hayabuchi N: Thalium-201 in brain tumors: relationship between tumour cell activity in astrocytic tumor and proliferating cell nuclear antigen. J Nucl Med 36: 2201-2206, 1995
19. Jinnouchi S, Hoshi H, Ohnishi T, Futami S, Nagamachi S, Watanabe K, Ueda T, Wakisaka S: Thalium-201 SPECT for predicting histological types of meningiomas. J Nucl Med 34: 2091-2094, 1993
20. O'Tuama LA, Ted Treves S, Larar JN, Packard AB, Kwan AJ, Barnes PD, Scott RM, Black PMcL, Madsen JR, Goumnerova LC, Sallan SE, Tarbell NJ: Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison. J Nucl Med 34: 1045-1051, 1993
21. Taki S, Kakuda K, Kakuma K, Kobayashi K, Ohashi M, Ito S, Yokoyama M, Annen Y, Tonami N: Tl-201 SPECT in the differential diagnosis of brain tumours. Nucl Med Commun 20: 637-645, 1999
22. Bagni B, Pinna L, Tamarozzi R, Cattaruzzi E, Marzola MC, Bagni I, Ceruti S, Valentini A, Zanasi A, Mavilla L: SPET imaging of intracranial tumours with 99mTc-sestamibi. Nucl Med Commun 16: 258-264, 1995
23. Soler C, Beauchesne P, Maatougui K, Schmitt T, Barral FG, Michel D, Dubois F, Brunon J: Technetium-99m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy. Eur J Nuc Med 25: 1649-1657, 1998
24. Kojima T, Mizumura S, Kumita S, Kumazaki T, Teramoto A: Is technetium-99 m-MIBI taken up by the normal pituitary gland? A comparison of normal pituitary glands and pituitary adenomas. Ann Nucl Med 15: 321-327, 2001
25. Perez-Monte JE, Brown ML, Clarke MR, Watson CG, Carty SE: Parathyroid hyperplasia, thymic carcinoid and pituitary adenoma detected with technetium-99m-MIBI in MEN type I. J Nucl Med 38: 1767-1769, 1997
26. Elligsen JD, Thompson JE, Frey HE, Kruv J: Correlation of (Na-K) ATPase activity with growth of normal and transformed cells. Exp Cell Res 87: 233-240, 1974
27. Kapucu LO, Akyuz C, Vural G, Oguz A, Atasever T, Buyukpamukcu M, Unlu M: Evaluation of therapy response in children with untreated malignant lymphomas using technetium-99m-sestamibi. J Nucl Med 38: 243-247, 1997
28. Cordobes MD, Starzee A, Delmon-Moingeon L, Blanchot C, Kouyoumdjian JC, Prevost G, Caglar M, Moretti JL: Technetium 99m-sestamibi uptake by human benign and malignant breast tumour cells: correlation with mdr gene expression. J Nucl Med 37: 286-289, 1996
29. Crane P, Laliberte R, Heminway S: Effect of mitochondrial viability and metabolism of technetium-99m sestamibi myocardial retention. Eur J Mucl Med 20: 20-25, 1993
30. Kasarow LB, Friedman H: Enhanced Na-K activated adenosine triphosphate acivity in transforming fibroblasts. Cancer Res 34: 1862-1865, 1974.
31. Vallabhaneni VR, Chiu ML, Kronauge JF, Piwnica-Worms D: Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99-sestamibi. J Nucl Med 35: 510-515, 1994
32. Yamamoto Y, Nishiyama Y, Satoh K, Takashima H, Ohkawa M, Fujita J, Kishi T, Matsuno S, Tanabe M: Comparative study of technetium-99 m-sestamibi and thallium-201 SPECT in predicting chemotherapeutic response in small cell lung cancer. J Nucl Med 39: 1626-1629, 1998
33. Andrews DW, Das R, Kim S, Zhang J, Curtis M: Technetium-MIBI as a glioma imaging agent for the assessment of multi-drug resistance. Neurosurgery 40: 1323-1334, 1997
34. Shibata Y, Matsumura A, Nose T: Effect of expression of P-glycoprotein on technetium-99m methoxyisobutylisonitrile single photon emission computed tomography of brain tumors. Neurol Med Chir (Tokyo) 42: 325-331, 2002